NEJM Group

CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

Posts Tagged ‘left ventricular assist device thrombosis’

RSS

January 6th, 2014

Selections from Richard Lehman’s Literature Review: January 6th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include the NAVIGATOR study, trials of stents, mitral valve repair vs. replacement, and more.

Categories: General
Tags: atherosclerotic renal-artery stenosis, beta-blockers, cardiac arrest, cardiopulmonary resuscitation, COPD, defibrillation, diabetes, diuretics, hypothermia, impaired glucose tolerance, Ischemic cardiomyopathy, left ventricular assist device thrombosis, mechanical chest compressions, medical therapy, mitral repair, mitral replacement, Mononuclear Bone Marrow Cells, severe ischemic mitral regurgitation, stents, Transendocardial Mesenchymal Stem Cells


  • Search the Archive

  • Archives by Date

  • RSS NEJM — Recent Cardiology Articles

    • An Incidental Finding Unraveled February 26, 2026
      When a physician’s own incidental finding sends her down a long and winding path to find answers, she finds herself overcome with worry — but also, eventually, a new appreciation for life.
    • Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years February 19, 2026
      In low-risk patients with severe aortic stenosis, transcatheter and surgical aortic-valve replacement led to similar 7-year survival and valve durability outcomes, with no evidence of differences in composite end points.
    • Secondary Prevention after Ischemic Stroke February 19, 2026
      After ischemic stroke, recurrence risk is reduced by identifying the stroke mechanism and targeting modifiable risk factors. Early diagnostic evaluation, prompt preventive therapy, and ongoing monitoring are central to care.
    • Thromboprophylaxis for Atrial Fibrillation in Patients with Drug-Eluting Stents February 12, 2026
      Stroke prevention is one of the pillars of treatment for patients with atrial fibrillation, and oral anticoagulation with a direct oral anticoagulant (DOAC) is now the preferred option for thromboprophylaxis.1 Nevertheless, patients with atrial fibrillation commonly have coexistent vascular disease, so they may present with an acute...
    • Case 5-2026: An 18-Year-Old Woman with Headache and Hypertension February 12, 2026
      An 18-year-old woman with chronic headaches was admitted to the pediatric intensive care unit for a hypertensive emergency. The potassium level was 2.0 mmol per liter. A diagnosis was made.
  • Tag Cloud

    • ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
NEJM Group

Copyright © 2026 Massachusetts Medical Society. All rights reserved.

The content of this site is intended for health care professionals. Copyright | Terms | Privacy Policy |